4Rajiv A. Addon angiotensin receptor blockade with maximized ACE inhibition[J]. Kidney Int,2001,59(6):2282.
5Iso K,Tada H,Kuboki K,et al. Longterm effect of epalrestat,an aldose reductase inhibitor, on the development of incipient diabetic nephropathy in type 2 diabetic patients[J]. J Diabetes Compalications, 2001,15 (5):241- 244.
6Whiteside CI,Dlugosz JA. Mesamgial cell protein kinase C isozyme activation in the diabetic milieu[-J]. Am J Physiol,2002,282(6): F975.
7Ishii H, Tada H, Isogai S. An aldose reductase inhibitor prevents glucose-induced increase in transforming growth factor-beta and protein kinase C activity in cultured mesangial ce-lls [J]. Diabeto logia, 1998,41 (3): 362-364.
8Phillips AO,Steadman R, Morrisey K, et al. Exposure of human renal proximal tubularcells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation[J]. Kidney Int, 1997,52(4) : 973-984.
